MEDNAX (MD) Misses Q2 EPS by 4c

MEDNAX (NYSE: MD) reported Q2 EPS of $1.03, $0.04 worse than the analyst estimate of $1.07. Revenue for the quarter came in at $772 million versus the consensus estimate of $775.68 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance
• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance